Nomograms for Optimization of Amikacin First Dose in Critically Ill Patients Using a Population Pharmacokinetics Model

Beta-lactams Therapeutic Drug Monitoring in Critically Ill Patients

NCT05352997 ·Status: COMPLETED

Population Pharmacokinetics of Anti-infectives in Hospitalized Patients

NCT02998411 ·Status: RECRUITING

Antibiotic Dosing in Pediatric Intensive Care

NCT02456974 ·Status: RECRUITING

Vancomycin Dose Adjustments Comparing Trough Levels to The AUC/MIC Method Using a Bayesian Approach in a Hospitalized Adult Population

NCT04756895 ·Status: COMPLETED ·Phase: NA

First Time Right of Vancomycin

NCT05964114 ·Status: NOT_YET_RECRUITING ·Phase: NA

Pharmacokinetics of Flucloxacillin Given by Continuous or Intermittent Infusion to ICU Patients

NCT02993575 ·Status: COMPLETED

Impact of Imipenem With Amikacin Pharmacokinetic and Pharmacodynamic

NCT00950222 ·Status: COMPLETED ·Phase: NA

Antibiotic Dosing in Geriatric Patients At the Emergency Department

NCT04436991 ·Status: RECRUITING

Medical Device (MD) Derived Pharmacokinetic (PK) Parameters for Vancomycin (MD-PK)

NCT05950984 ·Status: COMPLETED

Pharmacokinetics of Antibiotics in Patients Undergoing Renal Replacement Therapies

NCT03636464 ·Status: RECRUITING

Personalized Optimization of Antibiotic Therapy in Pulmonary Sepsis Critically Ill Patients Through Application of Rapid Microbiological Diagnostic Technologies and Pharmacokinetic/Pharmacodynamic Modelling

NCT06956053 ·Status: NOT_YET_RECRUITING ·Phase: NA

Pharmacodynamic Parameters of Two Different Doses of Cefepime

NCT00177736 ·Status: COMPLETED

Evaluation of the Pharmacokinetics of Caspofungin in ICU Patients

NCT02596984 ·Status: COMPLETED ·Phase: NA

The OPTIMAL TDM Study: Determining Optimal Beta-lactam Plasma Concentrations Through Therapeutic Drug Monitoring

NCT03790631 ·Status: COMPLETED

Optimizing Vancomycin Therapy in Children

NCT05691309 ·Status: COMPLETED

The Population Pharmacokinetics of Imipenem in Patients With Ventilator-associated Pneumonia

NCT01489124 ·Status: COMPLETED ·Phase: PHASE4

Tolerance and Efficacy of Amiklin Administration During Nosocomial Infections Complicating COVID-19 in the ICU

NCT05511129 ·Status: UNKNOWN

Pharmacokinetics of Piperacillin and Tazobactam in Critically Ill Patients

NCT03738683 ·Status: COMPLETED

Population Pharmacokinetic (PK) Study of Multiple Doses of Cubicin® (Daptomycin) 10 mg/kg in Critical Care Patients Having Bacteremia, Endocarditis or Skin Soft Tissue Infections Due to Gram Positive Bacteria With Various Degrees of Renal Failure

NCT02142075 ·Status: COMPLETED ·Phase: PHASE3

Population Pharmacokinetics of Antibiotics in Critically Ill Children (POPSICLE)

NCT03248349 ·Status: UNKNOWN

Model-Informed Precision Dosing on Amikacin and Vancomycin Therapy in Critically Ill Children

NCT07315438 ·Status: COMPLETED ·Phase: NA

Pharmacokinetics of Teicoplanin in Intensive Care and Haematology Patients

NCT04096092 ·Status: COMPLETED

Model-informed Precision Dosing of Vancomycin in Adults

NCT05535075 ·Status: COMPLETED ·Phase: PHASE4

To Evaluate the Pharmacokinetics of XNW4107 in Healthy Adult Young Females and in Healthy Adult Elderly Males and Females.

NCT04801043 ·Status: COMPLETED ·Phase: PHASE1

Optimization of Beta-lactam Dosing in Critically Ill Patients With Cystatin C (OPTIMIZE-GNI)

NCT06709521 ·Status: RECRUITING ·Phase: PHASE4